Emanuela Ferraro

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Emanuela Ferraro

Feb 9, 2025, 15:15 | Science

Elvina Almuradova: Survival outcomes for ERBB2-positive MBC patients with brain metastases

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 3, 2025, 13:44 | Blog

Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer

Nelson Moss, Neurosurgeon at Neurosurgery at Memorial Sloan Kettering, posted on X about recent paper by…

Aug 2, 2024, 02:02 | Blog

Sergio Cifuentes Canaval: Impact of CDK4/6 Inhibitors on Brain Metastases in HR+/HER2- Metastatic Breast Cancer

Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…

Jun 30, 2024, 10:58 | Insight

Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age

Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X: "Just out…

All: 4 Posts: 1 - 100

'

FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

'

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023